What to Know About Stem Cell Products Sold in South Carolina

Stem cell products are not regulated the same way as drugs or supplements, and most lack scientific evidence of safety or effectiveness

Stem cell treatments marketed in South Carolina—whether injected into joints, infused intravenously, or applied topically—operate in a gray zone between dietary supplements and medical drugs. The U.S. Food and Drug Administration (FDA) has not approved most stem cell products for treating arthritis, sports injuries, or degenerative conditions, even though clinics across the state advertise them for these purposes. This means there is no federal requirement that these products be tested for purity, potency, or safety before they reach patients.

The products sold vary widely. Some contain cells derived from bone marrow or fat tissue harvested from the patient's own body. Others use umbilical cord tissue or amniotic fluid from donated sources. A few are manufactured in laboratories. Each type carries different risks, and the actual contents may not match what the marketing materials claim. South Carolina does not have state-level oversight that would verify these claims or test the products before sale.

Key Takeaways

• The FDA has not approved most stem cell products sold in clinics, meaning they have not been tested for safety or effectiveness in the way prescription medications are.
• Stem cell treatments are not regulated as dietary supplements, so they do not have the same labeling or quality standards as vitamins or herbal products.
• Serious infections, allergic reactions, and tumor growth have been reported after stem cell injections, though these outcomes are rare.
• If you are considering a stem cell treatment, ask the clinic for peer-reviewed published research on the specific product and condition, not just testimonials.

How the FDA regulates stem cell products

The FDA treats most stem cell products as biologics—drugs made from living cells or tissues—rather than as supplements. This means they technically require FDA approval before being marketed. However, the FDA has created a narrow exception for products made from a patient's own cells, processed minimally, and used in the same patient during a single procedure. Even under this exception, the clinic must follow specific manufacturing standards and report adverse events.

In practice, many clinics operate outside these rules. They may claim their process qualifies for the exception when it does not, or they may simply proceed without seeking approval. The FDA has sent warning letters to clinics in South Carolina and across the country for making unproven claims or failing to meet manufacturing standards. Enforcement is slow, and by the time a warning is issued, patients may already have been treated.

What research actually shows about stem cell treatments

Clinical trials for stem cell treatments in joint and tissue repair are ongoing, but results so far are mixed. Some small studies suggest that stem cells from a patient's own fat or bone marrow may reduce pain in osteoarthritis or tendon injuries, but the effect sizes are modest and the studies often lack control groups. Large, rigorous trials that would establish whether stem cells work better than placebo or existing treatments are rare.

For many conditions marketed by clinics—spinal cord injury, Parkinson's disease, heart failure—there is no published evidence that any stem cell product is effective. The absence of evidence is not the same as evidence of absence, but it means you cannot know whether you are paying for a treatment that works or one that does not. Testimonials and before-and-after photos are not substitutes for clinical data.

Risks and complications reported after stem cell injections

Serious adverse events are uncommon but documented. Patients have developed infections at injection sites, allergic or inflammatory reactions to the injected material, and in rare cases, tumors. Some complications appeared months or years after treatment. Others occurred because the stem cells migrated to unintended locations in the body or because the injection itself damaged nearby tissue.

The risk varies by the type of product, the source of the cells, how they were processed, and where they were injected. Intravenous infusions carry different risks than joint injections. Products made from a patient's own cells generally carry lower infection risk than those made from donated tissue, but contamination during processing can occur. Clinics that do not follow strict sterile protocols increase the risk of infection.

Questions to ask a clinic before pursuing stem cell treatment

If a clinic in South Carolina is offering stem cell treatment for your condition, ask for the names of peer-reviewed published studies on that specific product and that specific condition. Do not accept references to studies on a different product or a different condition. Ask whether the clinic has FDA approval or an FDA exemption letter for the product, and request to see it.

Ask what the cells are made from, how they were processed, and where they were sourced. Ask about the clinic's quality control procedures—how do they verify that the product is sterile and contains what they say it contains? Ask for a written list of known risks and complications. Ask whether the clinic reports adverse events to the FDA. If the clinic cannot or will not answer these questions clearly, that is a signal to seek a second opinion from a physician at an academic medical center or a board-certified specialist in your condition.

Alternatives to consider before choosing stem cell treatment

For joint pain and arthritis, physical therapy, weight management, and anti-inflammatory medications have strong evidence behind them. Corticosteroid injections and hyaluronic acid injections are FDA-approved and have been used safely for decades. Platelet-rich plasma (PRP) injections, which use a concentrate of your own blood platelets, are less regulated than stem cells but have a longer track record and lower cost.

For spinal cord injury, heart disease, and neurological conditions, clinical trials are the most rigorous way to access experimental treatments while contributing to medical knowledge. The National Institutes of Health maintains a searchable database of clinical trials at ClinicalTrials.gov. Trials offer free treatment, close medical monitoring, and the assurance that the treatment is being studied under FDA oversight.

How to report a problem with a stem cell product

If you received a stem cell treatment and experienced an unexpected reaction or complication, you can report it to the FDA through MedWatch, the FDA's safety reporting system. You can file a report online at fda.gov/medwatch or by phone at 1-888-SAFEFDA. You do not need to prove that the product caused the problem—the FDA uses reports to identify patterns and safety signals.

You can also file a complaint with the South Carolina Department of Health and Environmental Control (DHEC) if you believe the clinic violated state health regulations. Contact DHEC's Office of Regulatory Services or the Board of Medical Examiners if the clinic is run by a licensed physician. These agencies can investigate and take action if warranted.

Frequently Asked Questions

Is stem cell treatment covered by insurance in South Carolina?

Most insurance plans, including Medicare, do not cover stem cell treatments because they are not FDA-approved for most conditions. Clinics typically require out-of-pocket payment, which can range from a few hundred to tens of thousands of dollars depending on the treatment. Before paying, confirm with your insurance company whether coverage is possible for your specific condition.

Can I get stem cell treatment from a hospital or university medical center in South Carolina?

Some academic medical centers and hospitals offer stem cell treatments as part of clinical trials or FDA-approved protocols. These settings have stricter oversight and safety standards than private clinics. Contact the research or clinical trial office at a major medical center in your area to ask whether they are enrolling patients for your condition.

What does "minimally processed" mean when clinics describe their stem cells?

Minimally processed means the cells are taken from your body, washed or concentrated, and injected back into you without being grown in culture or genetically modified. The FDA allows this under certain conditions, but "minimally processed" does not mean unregulated or risk-free. Ask the clinic to explain exactly what steps they take and whether they have FDA documentation for their process.

Are stem cell products the same as PRP injections?

No. PRP (platelet-rich plasma) uses concentrated platelets from your own blood and is less heavily regulated than stem cell products. Both are marketed for joint and tissue injuries, but they work through different mechanisms. PRP has a longer history of use and lower cost, though evidence for both treatments remains limited.

What should I do if a clinic pressures me to decide quickly on stem cell treatment?

Pressure to decide quickly is a red flag. Legitimate medical decisions can wait a few days while you gather information, get a second opinion, or research the clinic's background. Take time to ask questions, review published research, and consult with a physician who has no financial interest in the treatment.